Oak Street Health Announces the Pricing of Secondary Offering

Rhea-AI Summary

Oak Street Health (NYSE: OSH) has priced its underwritten public offering of 7 million shares at $25.75 each, with a further option for underwriters to purchase 1.05 million additional shares. The offering is set to close on August 19, 2022. Importantly, Oak Street will not receive any proceeds from this sale, which is led by a selling stockholder. J.P. Morgan, Goldman Sachs & Co., and others are managing the offering. This announcement highlights the company's position as a primary care provider for adults on Medicare.

Positive

• Public offering of 7 million shares priced at $25.75 per share, providing liquidity to the market.
• Underwriters have a 30-day option to purchase an additional 1.05 million shares, indicating strong interest.

Negative

• Oak Street will not receive proceeds from the sale, which may affect its funding and operational flexibility.

CHICAGO--(BUSINESS WIRE)-- Oak Street Health, Inc. (“Oak Street”) (NYSE: OSH), a network of value-based, primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced the pricing of its previously announced underwritten public offering of 7,000,000 shares of its common stock by a selling stockholder at a public offering price of $25.75 per share. Such selling stockholder also granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of Oak Street’s common stock. Oak Street will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholder, and the selling stockholder will bear the underwriting discounts and commissions associated with the sale of such shares. The offering is expected to close on August 19, 2022, subject to customary closing conditions.

J.P. Morgan, Goldman Sachs & Co. LLC, Morgan Stanley, William Blair and Piper Sandler are acting as joint book running managers for the proposed offering.

A shelf registration statement on Form S-3 (including a prospectus) relating to the securities being sold in the offering was deemed automatically effective upon filing with the Securities and Exchange Commission. A copy of the final prospectus, when available, may be obtained for free by visiting EDGAR on the SEC website at www.sec.gov, or by contacting: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 1-866- 803-9204 or email at prospectus-eq_fi@jpmchase.com; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: prospectus-ny@ny.email.gs.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014; William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606; via telephone at (800) 621-0687 or via email: prospectus@williamblair.com; or Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at (800) 747-3924 or via email at prospectus@psc.com.

This press release is neither an offer to sell nor a solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation or sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Oak Street Health:

Founded in 2012, Oak Street Health is a network of value-based primary care centers for adults on Medicare. With a mission of rebuilding healthcare as it should be, the Company operates an innovative healthcare model focused on quality of care over volume of services, and assumes the full financial risk of its patients. Oak Street Health currently operates more than 140 centers across 20 states and is the only primary care provider to carry the AARP name.

Forward-Looking Statements

Certain of the statements made in this press release are forward looking within the meaning of the Private Securities Litigation Reform Act of 1995, such as those, among others, statements concerning the expected closing of the offering. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to the satisfaction of customary closing conditions related to the offering and the impact of general economic, industry or political conditions in the United States or internationally. There can be no assurance that Oak Street will be able to complete the offering on the anticipated terms, or at all. You should not place undue reliance on these forward-looking statements as predictions of future events, which statements apply only as of the date of this press release. Additional risks and uncertainties relating to the offering, Oak Street and its business can be found under the heading "Risk Factors" in Oak Street’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, each filed with the Securities and Exchange Commission. Forward-looking statements represent Oak Street’s beliefs and assumptions only as of the date of this press release. Oak Street expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based, except as may be required under applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220816005933/en/

Media:

Erica Frank

Vice President of Public Relations

(330) 990-5026

Erica.Frank@oakstreethealth.com

Investors:

Sarah Cluck

Head of Investor Relations

(773) 572-0254

sarah.cluck@oakstreethealth.com

Source: Oak Street Health

FAQ

What is the public offering price of Oak Street Health's shares?

The public offering price of Oak Street Health's shares is $25.75 each.

How many shares is Oak Street Health offering in the public offering?

Oak Street Health is offering 7 million shares in the public offering.

When is the closing date for the Oak Street Health offering?

The offering is expected to close on August 19, 2022.

Will Oak Street Health receive any proceeds from the share offering?

No, Oak Street Health will not receive any proceeds from the sale of shares.

What companies are managing the Oak Street Health share offering?

J.P. Morgan, Goldman Sachs & Co., Morgan Stanley, William Blair, and Piper Sandler are managing the offering.